Compound details
Litsealactone
| Compound ID | CDAMM02886 |
|---|---|
| Common name | Litsealactone | IUPAC name | (3,8-dimethyl-13-oxo-5,14-dioxatricyclo[10.2.1.02,6]pentadeca-2(6),3,8,12(15)-tetraen-7-yl) acetate |
| Molecular formula | C17H18O5 |
| Retention time | 3.28 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 303.125 | Theoretical mz | 303.122 |
| Error | 8.33 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 8.0533 |
| Inchi key | QLCCQRBUPHVRDT-UITAMQMPNA-N |
|---|---|
| Smiles | O=C1OC2C=C1CCC=C(C)C(OC(=O)C)C=3OC=C(C32)C |
| Superclass | Organoheterocyclic compounds |
| Class | Dihydrofurans |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q9Y5N1 | HRH3 | Histamine H3 receptor | T64765 | SwissTargetPrediction |
| P08173 | CHRM4 | Muscarinic acetylcholine receptor M4 | T20709 | SwissTargetPrediction |
| P00533 | EGFR | Epidermal growth factor receptor erbB1 | T59328 | SwissTargetPrediction |
| P29274 | ADORA2A | Adenosine A2a receptor | T77365 | SwissTargetPrediction |
| Q16853 | AOC3 | Amine oxidase, copper containing | T69619 | SwissTargetPrediction |
| Q99720 | SIGMAR1 | Sigma opioid receptor | T46360 | SwissTargetPrediction |
| P41594 | GRM5 | Metabotropic glutamate receptor 5 | T99347 | SwissTargetPrediction |
| P21917 | DRD4 | Dopamine D4 receptor | T24983 | SwissTargetPrediction |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| P11940 | PABPC1 | Polyadenylate-binding protein 1 | T58679 | SwissTargetPrediction |
| Q02083 | NAAA | N-acylsphingosine-amidohydrolase (by homology) | T78326 | SwissTargetPrediction |
| P31645 | SLC6A4 | Serotonin transporter (by homology) | T27812 | SwissTargetPrediction |
| Q96RJ0 | TAAR1 | Trace amine-associated receptor 1 (by homology) | T99524 | SwissTargetPrediction |
| P08913 | ADRA2A | Alpha-2a adrenergic receptor | T11448 | SwissTargetPrediction |
| P29275 | ADORA2B | Adenosine A2b receptor | T86679 | SwissTargetPrediction |
| P43235 | CTSK | Cathepsin K | T11388 | SwissTargetPrediction |
| P15538 | CYP11B1 | Cytochrome P450 11B1 | T84621 | SwissTargetPrediction |
| P19099 | CYP11B2 | Cytochrome P450 11B2 | T59056 | SwissTargetPrediction |
| Q99705 | MCHR1 | Melanin-concentrating hormone receptor 1 | T09572 | SwissTargetPrediction |
| P10275 | AR | Androgen Receptor | T11211 | SwissTargetPrediction |
| Q92731 | ESR2 | Estrogen receptor beta | T80896 | SwissTargetPrediction |
| O60885 | BRD4 | Bromodomain-containing protein 4 | T00407 | SwissTargetPrediction |
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SwissTargetPrediction |
| Q9H3N8 | HRH4 | Histamine H4 receptor | T26500 | SwissTargetPrediction |
| P28845 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | T65200 | SwissTargetPrediction |
| P03372 | ESR1 | Estrogen receptor alpha | T02506 | SwissTargetPrediction |
| P09917 | ALOX5 | Arachidonate 5-lipoxygenase | T00140 | SwissTargetPrediction |
| O00206 | TLR4 | Toll-like receptor 4 (by homology) | T81443 | SwissTargetPrediction |
| P08069 | IGF1R | Insulin-like growth factor I receptor | T48069 | SwissTargetPrediction |
| P18825 | ADRA2C | Adrenergic receptor alpha-2 | T01777 | SwissTargetPrediction |
| P35372 | OPRM1 | Mu opioid receptor | T47768 | SwissTargetPrediction |
| P35368 | ADRA1B | Alpha-1b adrenergic receptor | T29500 | SwissTargetPrediction |
| Q9H2K2 | TNKS2 | Tankyrase-2 | T38087 | SwissTargetPrediction |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| O60674 | JAK2 | Tyrosine-protein kinase JAK2 | T08391 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| O75874 | IDH1 | Isocitrate dehydrogenase [NADP] cytoplasmic | T69563 | SwissTargetPrediction |
| P08172 | CHRM2 | Muscarinic acetylcholine receptor M2 | T46185 | SwissTargetPrediction |
| P07711 | CTSL | Cathepsin L | T98691 | SwissTargetPrediction |
| P07858 | CTSB | Cathepsin (B and K) | T61746 | SwissTargetPrediction |
| P41143 | OPRD1 | Delta opioid receptor | T58992 | SwissTargetPrediction |
| P48147 | PREP | Prolyl endopeptidase | T86161 | SwissTargetPrediction |
| P49810 | PSEN2 | Gamma-secretase | T99204 | SwissTargetPrediction |
| Q99572 | P2RX7 | P2X purinoceptor 7 | T63414 | SwissTargetPrediction |
| Q13627 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | T92803 | SwissTargetPrediction |
| P25774 | CTSS | Cathepsin S | T68290 | SwissTargetPrediction |
| Q9NR96 | TLR9 | Toll-like receptor (TLR7/TLR9) | T11451 | SwissTargetPrediction |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction |
| P48039 | MTNR1A | Melatonin receptor 1A | T97613 | SwissTargetPrediction |
| P49286 | MTNR1B | Melatonin receptor 1B | T48268 | SwissTargetPrediction |
| P18089 | ADRA2B | Alpha-2b adrenergic receptor | T41580 | SwissTargetPrediction |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SwissTargetPrediction |
| P06737 | PYGL | Liver glycogen phosphorylase | T19184 | SwissTargetPrediction |
| P30536 | TSPO | Translocator protein (by homology) | T75440 | SwissTargetPrediction |
| P22460 | KCNA5 | Voltage-gated potassium channel subunit Kv1.5 | T17569 | SwissTargetPrediction |
| Q05469 | LIPE | Hormone sensitive lipase | T55689 | SwissTargetPrediction |
| Q9UKP6 | UTS2R | Urotensin II receptor | T49072 | SwissTargetPrediction |
| P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha 3 | T03279 | SwissTargetPrediction |
| Q9UHC3 | ASIC3 | Amiloride-sensitive cation channel 3 | T95947 | SwissTargetPrediction |
| P30281 | CCND3 | Cyclin-dependent kinase 4/cyclin D | T72507 | SwissTargetPrediction |
| Q9BUB5 | MKNK1 | MAP kinase-interacting serine/threonine-protein kinase MNK1 | T97136 | SwissTargetPrediction |
| P63316 | TNNC1 | Troponin, cardiac muscle | T12966 | SwissTargetPrediction |
| Q13822 | ENPP2 | Autotaxin | T63512 | SwissTargetPrediction |
| O60911 | CTSV | Cathepsin (V and K) | T93653 | SwissTargetPrediction |
| P53634 | CTSC | Dipeptidyl peptidase I | T70490 | SwissTargetPrediction |
| P49768 | PSEN1 | Presenilin 1 | T93105 | SwissTargetPrediction |
| P63165 | SUMO1 | Small ubiquitin-related modifier 1 | T99765 | SwissTargetPrediction |
| Q9UBX1 | CTSF | Cathepsin F | T77236 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T64765 | DI0392 | Somnolence | [ICD-11: MG42] | Q9Y5N1 | HRH3 |
| T20709 | DI0037 | Asthma | [ICD-11: CA23] | P08173 | CHRM4 |
| T20709 | DI0141 | Eye anterior segment structural developmental anomaly | [ICD-11: LA11] | P08173 | CHRM4 |
| T20709 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08173 | CHRM4 |
| T20709 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P08173 | CHRM4 |
| T20709 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P08173 | CHRM4 |
| T59328 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00533 | EGFR |
| T59328 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00533 | EGFR |
| T59328 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P00533 | EGFR |
| T59328 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P00533 | EGFR |
| T59328 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00533 | EGFR |
| T59328 | DI0238 | Lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P00533 | EGFR |
| T59328 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00533 | EGFR |
| T59328 | DI0420 | Unspecific body region injury | [ICD-11: ND56] | P00533 | EGFR |
| T77365 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P29274 | ADORA2A |
| T77365 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P29274 | ADORA2A |
| T77365 | DI0359 | Radionuclide imaging | [ICD-11: N.A.] | P29274 | ADORA2A |
| T69619 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | Q16853 | AOC3 |
| T46360 | DI0105 | Cough | [ICD-11: MD12] | Q99720 | SIGMAR1 |
| T99347 | DI0152 | Fragile X chromosome | [ICD-11: LD55] | P41594 | GRM5 |
| T99347 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P41594 | GRM5 |
| T24983 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21917 | DRD4 |
| T24983 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P21917 | DRD4 |
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T58679 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11940 | PABPC1 |
| T27812 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P31645 | SLC6A4 |
| T27812 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P31645 | SLC6A4 |
| T27812 | DI0087 | Chronic pain | [ICD-11: MG30] | P31645 | SLC6A4 |
| T27812 | DI0096 | concerning food/fluid intake symptom | [ICD-11: MG43] | P31645 | SLC6A4 |
| T27812 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P31645 | SLC6A4 |
| T27812 | DI0105 | Cough | [ICD-11: MD12] | P31645 | SLC6A4 |
| T27812 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P31645 | SLC6A4 |
| T27812 | DI0264 | Migraine | [ICD-11: 8A80] | P31645 | SLC6A4 |
| T27812 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P31645 | SLC6A4 |
| T27812 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P31645 | SLC6A4 |
| T27812 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P31645 | SLC6A4 |
| T99524 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q96RJ0 | TAAR1 |
| T99524 | DI0149 | Focal/segmental autonomic disorder | [ICD-11: 8D8A] | Q96RJ0 | TAAR1 |
| T99524 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q96RJ0 | TAAR1 |
| T11448 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P08913 | ADRA2A |
| T11448 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P08913 | ADRA2A |
| T11448 | DI0396 | Substance abuse | [ICD-11: 6C40] | P08913 | ADRA2A |
| T86679 | DI0180 | Herpes simplex infection | [ICD-11: 1F00] | P29275 | ADORA2B |
| T86679 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P29275 | ADORA2B |
| T11388 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P43235 | CTSK |
| T84621 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P15538 | CYP11B1 |
| T84621 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P15538 | CYP11B1 |
| T59056 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P19099 | CYP11B2 |
| T09572 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q99705 | MCHR1 |
| T11211 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P10275 | AR |
| T11211 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10275 | AR |
| T11211 | DI0021 | Alcoholic liver disease | [ICD-11: DB94] | P10275 | AR |
| T11211 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10275 | AR |
| T11211 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P10275 | AR |
| T11211 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P10275 | AR |
| T11211 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P10275 | AR |
| T11211 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P10275 | AR |
| T11211 | DI0247 | Mammary tumour | [ICD-11: 2C60-2C6Z] | P10275 | AR |
| T11211 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P10275 | AR |
| T11211 | DI0401 | Testicular dysfunction | [ICD-11: 5A81] | P10275 | AR |
| T80896 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q92731 | ESR2 |
| T80896 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | Q92731 | ESR2 |
| T80896 | DI0254 | Menopausal disorder | [ICD-11: GA30] | Q92731 | ESR2 |
| T80896 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q92731 | ESR2 |
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T26500 | DI0037 | Asthma | [ICD-11: CA23] | Q9H3N8 | HRH4 |
| T26500 | DI0039 | Atopic eczema | [ICD-11: EA80] | Q9H3N8 | HRH4 |
| T26500 | DI0351 | Psoriasis | [ICD-11: EA90] | Q9H3N8 | HRH4 |
| T26500 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9H3N8 | HRH4 |
| T26500 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q9H3N8 | HRH4 |
| T65200 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P28845 | HSD11B1 |
| T65200 | DI0239 | Lupus erythematosus | [ICD-11: 4A40] | P28845 | HSD11B1 |
| T65200 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P28845 | HSD11B1 |
| T02506 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P03372 | ESR1 |
| T00140 | DI0037 | Asthma | [ICD-11: CA23] | P09917 | ALOX5 |
| T00140 | DI0147 | Filariasis | [ICD-11: 1F66] | P09917 | ALOX5 |
| T00140 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P09917 | ALOX5 |
| T81443 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | O00206 | TLR4 |
| T81443 | DI0346 | Prostate cancer | [ICD-11: 2C82] | O00206 | TLR4 |
| T81443 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | O00206 | TLR4 |
| T48069 | DI0276 | Multiple structural anomalies syndrome | [ICD-11: LD2F] | P08069 | IGF1R |
| T48069 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P08069 | IGF1R |
| T48069 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P08069 | IGF1R |
| T01777 | DI0166 | Glaucoma | [ICD-11: 9C61] | P18825 | ADRA2C |
| T01777 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P18825 | ADRA2C |
| T01777 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P18825 | ADRA2C |
| T01777 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18825 | ADRA2C |
| T01777 | DI0310 | Ocular disease | [ICD-11: N.A.] | P18825 | ADRA2C |
| T01777 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18825 | ADRA2C |
| T47768 | DI0013 | Acute pain | [ICD-11: MG31] | P35372 | OPRM1 |
| T47768 | DI0059 | Bowel habit change | [ICD-11: ME05] | P35372 | OPRM1 |
| T47768 | DI0087 | Chronic pain | [ICD-11: MG30] | P35372 | OPRM1 |
| T47768 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P35372 | OPRM1 |
| T47768 | DI0105 | Cough | [ICD-11: MD12] | P35372 | OPRM1 |
| T47768 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35372 | OPRM1 |
| T47768 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P35372 | OPRM1 |
| T47768 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P35372 | OPRM1 |
| T47768 | DI0228 | Large intestine motility disorder | [ICD-11: DB32] | P35372 | OPRM1 |
| T47768 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P35372 | OPRM1 |
| T47768 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35372 | OPRM1 |
| T47768 | DI0349 | Pruritus | [ICD-11: EC90] | P35372 | OPRM1 |
| T47768 | DI0374 | Sensation disturbance | [ICD-11: MB40] | P35372 | OPRM1 |
| T29500 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P35368 | ADRA1B |
| T29500 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P35368 | ADRA1B |
| T29500 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P35368 | ADRA1B |
| T29500 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P35368 | ADRA1B |
| T29500 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35368 | ADRA1B |
| T38087 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | Q9H2K2 | TNKS2 |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T08391 | DI0039 | Atopic eczema | [ICD-11: EA80] | O60674 | JAK2 |
| T08391 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60674 | JAK2 |
| T08391 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | O60674 | JAK2 |
| T08391 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | O60674 | JAK2 |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T69563 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | O75874 | IDH1 |
| T46185 | DI0037 | Asthma | [ICD-11: CA23] | P08172 | CHRM2 |
| T46185 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08172 | CHRM2 |
| T46185 | DI0278 | Muscle disorder | [ICD-11: FB32-FB3Z] | P08172 | CHRM2 |
| T46185 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P08172 | CHRM2 |
| T46185 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P08172 | CHRM2 |
| T46185 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P08172 | CHRM2 |
| T98691 | DI0263 | Middle East Respiratory Syndrome | [ICD-11: 1D64] | P07711 | CTSL |
| T98691 | DI0376 | Severe acute respiratory syndrome | [ICD-11: 1D65] | P07711 | CTSL |
| T61746 | DI0023 | Alopecia | [ICD-11: ED70] | P07858 | CTSB |
| T61746 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P07858 | CTSB |
| T61746 | DI0037 | Asthma | [ICD-11: CA23] | P07858 | CTSB |
| T61746 | DI0055 | Bone cancer | [ICD-11: 2B5Z] | P07858 | CTSB |
| T61746 | DI0060 | Brain cancer | [ICD-11: 2A00] | P07858 | CTSB |
| T61746 | DI0067 | Cardiac arrest | [ICD-11: MC82] | P07858 | CTSB |
| T61746 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | P07858 | CTSB |
| T61746 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P07858 | CTSB |
| T61746 | DI0087 | Chronic pain | [ICD-11: MG30] | P07858 | CTSB |
| T61746 | DI0110 | Cystic fibrosis | [ICD-11: CA25] | P07858 | CTSB |
| T61746 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P07858 | CTSB |
| T61746 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P07858 | CTSB |
| T61746 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P07858 | CTSB |
| T61746 | DI0253 | Meningioma | [ICD-11: 2A01] | P07858 | CTSB |
| T61746 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P07858 | CTSB |
| T61746 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P07858 | CTSB |
| T61746 | DI0296 | Neurodegenerative disorder | [ICD-11: 8A20-8A23] | P07858 | CTSB |
| T61746 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P07858 | CTSB |
| T61746 | DI0351 | Psoriasis | [ICD-11: EA90] | P07858 | CTSB |
| T61746 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P07858 | CTSB |
| T58992 | DI0059 | Bowel habit change | [ICD-11: ME05] | P41143 | OPRD1 |
| T58992 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P41143 | OPRD1 |
| T58992 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41143 | OPRD1 |
| T86161 | DI0092 | Coeliac disease | [ICD-11: DA95] | P48147 | PREP |
| T86161 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P48147 | PREP |
| T86161 | DI0238 | Lung cancer | [ICD-11: 2C25] | P48147 | PREP |
| T86161 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P48147 | PREP |
| T99204 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P49810 | PSEN2 |
| T99204 | DI0380 | Shoulder lesion | [ICD-11: FB53] | P49810 | PSEN2 |
| T99204 | DI0390 | Soft tissue disorder | [ICD-11: FB56] | P49810 | PSEN2 |
| T63414 | DI0224 | Joint pain | [ICD-11: ME82] | Q99572 | P2RX7 |
| T92803 | DI0113 | Cytomegaloviral disease | [ICD-11: 1D82] | Q13627 | DYRK1A |
| T68290 | DI0042 | Autoimmune disease | [ICD-11: 4A40-4A45] | P25774 | CTSS |
| T68290 | DI0092 | Coeliac disease | [ICD-11: DA95] | P25774 | CTSS |
| T68290 | DI0107 | Crohn disease | [ICD-11: DD70] | P25774 | CTSS |
| T68290 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P25774 | CTSS |
| T68290 | DI0163 | General pain disorder | [ICD-11: 8E43] | P25774 | CTSS |
| T68290 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P25774 | CTSS |
| T68290 | DI0382 | Sjogren syndrome | [ICD-11: 4A43] | P25774 | CTSS |
| T11451 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | Q9NR96 | TLR9 |
| T11451 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | Q9NR96 | TLR9 |
| T11451 | DI0252 | Melanoma | [ICD-11: 2C30] | Q9NR96 | TLR9 |
| T11451 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q9NR96 | TLR9 |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T97613 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P48039 | MTNR1A |
| T48268 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P49286 | MTNR1B |
| T41580 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18089 | ADRA2B |
| T75440 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P30536 | TSPO |
| T75440 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P30536 | TSPO |
| T75440 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P30536 | TSPO |
| T75440 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P30536 | TSPO |
| T75440 | DI0271 | Mood/affect symptom | [ICD-11: MB24] | P30536 | TSPO |
| T75440 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P30536 | TSPO |
| T17569 | DI0030 | Angina pectoris | [ICD-11: BA40] | P22460 | KCNA5 |
| T55689 | DI0332 | Pediculosis | [ICD-11: 1G00] | Q05469 | LIPE |
| T49072 | DI0037 | Asthma | [ICD-11: CA23] | Q9UKP6 | UTS2R |
| T03279 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P51812 | RPS6KA3 |
| T95947 | DI0087 | Chronic pain | [ICD-11: MG30] | Q9UHC3 | ASIC3 |
| T95947 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q9UHC3 | ASIC3 |
| T97136 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q9BUB5 | MKNK1 |
| T97136 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | Q9BUB5 | MKNK1 |
| T97136 | DI0235 | Liver cancer | [ICD-11: 2C12] | Q9BUB5 | MKNK1 |
| T97136 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9BUB5 | MKNK1 |
| T97136 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9BUB5 | MKNK1 |
| T12966 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P63316 | TNNC1 |
| T12966 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P63316 | TNNC1 |
| T63512 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | Q13822 | ENPP2 |
| T93653 | DI0055 | Bone cancer | [ICD-11: 2B5Z] | O60911 | CTSV |
| T93653 | DI0087 | Chronic pain | [ICD-11: MG30] | O60911 | CTSV |
| T70490 | DI0064 | Bronchiectasis | [ICD-11: CA24] | P53634 | CTSC |
| T93105 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P49768 | PSEN1 |
| T93105 | DI0380 | Shoulder lesion | [ICD-11: FB53] | P49768 | PSEN1 |
| T93105 | DI0390 | Soft tissue disorder | [ICD-11: FB56] | P49768 | PSEN1 |
| T99765 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P63165 | SUMO1 |
| T77236 | DI0055 | Bone cancer | [ICD-11: 2B5Z] | Q9UBX1 | CTSF |
| T77236 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | Q9UBX1 | CTSF |
| T77236 | DI0087 | Chronic pain | [ICD-11: MG30] | Q9UBX1 | CTSF |
| T77236 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | Q9UBX1 | CTSF |
| T77236 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | Q9UBX1 | CTSF |
| T77236 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | Q9UBX1 | CTSF |
| T77236 | DI0351 | Psoriasis | [ICD-11: EA90] | Q9UBX1 | CTSF |